Company Profile 2011

Transcription

1 Company Profile 2011

2 Disclaimer This presentation contains forward-looking statements based on the currently held beliefs and assumptions of our management, which are expressed in good faith and in their opinion reasonable. Forward-looking statements involve known and unknown risks, uncertainties and other factors, which may cause our actual results, financial condition or performance or industry results to differ materially from the results, financial condition or performance expressed or implied by such forwardlooking statements. Given these risks, uncertainties and other factors, viewers of this presentation are cautioned not to place undue reliance on these forwardlooking statements. We disclaim any obligation to update this presentation to reflect future events or developments. 1

3 Company Overview Established in 1992, headquartered in Bengaluru, Karnataka, India, presence in an evolving knowledge intensive medical technology industry Develops, manufactures and markets medical equipment and consumables (non invasive) and interventional devices (invasive) Leader in cardiac and vital signs monitoring, emergency cardiac care, vascular treatments and sensing technologies 168 patents and 53 pending patent applications USFDA listed and CE marked products Markets more than 100 countries; predominant in North America, Europe and BRIC 200 Best under a Billion (2008, 2009) 2

4 Our Product Portfolio Noninvasive Patient monitors Oximeters, vital signs, cardiology, respiratory and anesthesia care Defibrillation (AEDs) PAD Diagnostics Consumables Invasive Cardiac Bare metal stents Coated stents and balloons Peripheral coated balloons Replacement implants Catheters 3

5 Our Product Brands Quinton Burdick Powerheart Pyramis HeartCentrix CareCenter MD ncompass ngenuity etraq equality evision PoetIQ MediChek Revo Dior Magical Genius Magic Genius Taxcor Freeway Amadeus Supercross emagic eflex 4

6 Our Target Customers Primary Care Physicians Specialty Practices Community Centres Nursing Homes; Clinics; Offices Surgery Centres Government Centres & Offices Emergency Svc; Hospitals Catheterization Labs Schools & Athletics Cardiac Rehabilitation Veterinary Facilities Military & Veteran Clinics 5

7 OEM Portfolio We started in 1992 as OEM suppliers for pulse oximetry sensors. Today, we white-label many consumables, chief of which are: Reusable and Disposable sensors (Consumables) Water Traps for Gas Benches (Consumables) 9100 CO 2 Module (Anesthesia module) 6

8 Facilities Manufacturing: R&D: USA: Wisconsin - Deerfield - Waukesha Rhode Island India: Bengaluru Chennai Vizag Kolkata Parwanoo Malaysia: Johor USA: Wisconsin Washington California Germany: Bonn India: Bengaluru 7

9 Vital Signs Monitoring Current Global value: $7Bn 2015: $8Bn+ CAGR: 3% Single-Parameter Monitor Growth Drivers: Technological advances Aging population Infrastructure in emerging markets Multi-Parameter Modular Monitor 1. The Future of the Patient Monitoring Market to 2015,Global Markets, September The Associated Chambers of Commerce and Industry of India, Paper on Healthcare Services, March 2010 Portable Multi-Parameter Monitor 8

10 Anesthesia Monitoring Current Global value: $4.8Bn 2016: $7.3Bn+ CAGR: 7% Growth Drivers: Growing safety awareness Technology enhancements Government regulation Anesthesia module Multi-Parameter Monitor with Gas Bench 1. Anesthesia Devices A Global Market Overview, Industry Experts, May

11 Peripheral Vascular Equipment Current Global Value: $180Mn 2016: $300Mn CAGR: 8% Growth Drivers: Peripheral Arterial Disease (PAD) awareness New detection technologies PAD Statistics US: 10 mn with lower-limb PAD, <20% diagnosed by a physician. 1 India: 20 mn PAD and critical limb ischemia are significantly underestimated. 2 PAD Diagnosis System PAD Diagnosis Monitor 1. US Peripheral Vascular device Market, idata Research, May India PAD Statistics, The Sage Group, November

12 External Defibrillation Market Current Global Value:$600 Mn : $842 Mn CAGR: 7% 1 Growth Drivers: Broadening awareness of the incidence of sudden cardiac arrest Increasing government legislation promoting or requiring external defibrillator installation Developing opportunity for emerging markets penetration Automated and semi-automated External Defibrillators 1. Frost & Sullivan, 2003, 2009 and company estimates 11

13 Cardiac Monitoring Devices Current Global Value: $635 Mn : $754 Mn CAGR: 3.5% Growth Drivers: Broadening global incidence of cardiac disease Increasing acceptance of remote and continuous monitoring technologies Developing opportunity for emerging markets penetration 1 Stress Testing Systems Holter Monitoring Systems 1. Frost & Sullivan, June 2008, 2010 Stress Test & Diagnostic Workstation ECG System 12

14 Coronary Stent Market Current Global Value: $5.4Bn : $6.5Bn CAGR: 2.5% Growth Drivers: Dramatic rise in cardiovascular disease Acceptance of minimally invasive procedures Infrastructure expansion Combination Device Bare Metal Stent & Drug-Eluting Balloon Stainless Steel Drug-Eluting Stent Cobalt Chromium Bare Metal Stent 1 Global Coronary Stents Equipment Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016,Global Data, June

15 Drug-Eluting Balloons (DEB) Current Global Value: ~$0.8Bn : $1.3 Bn CAGR: 7% Germany is currently the largest market 2 India growth rate = 8.1%; Australia = 7.9% 2 DEB cost effectiveness vs. DES to drive growth 2 Drug-Eluting Balloon for Coronary use Growth Drivers: Minimally invasive alternative to bypass surgery Reduction in cost and safer than DES Aging population Drug-Eluting Balloon for Peripheral use 1. Company Estimates 2. Global Drug-eluting Balloons Pipeline Analysis, Opportunity Assessments and Market forecasts to 2016, Global Industry Analysts, Inc., April

16 Acquisitions Monitoring Division of Palco Labs, USA Altron Industries, India Devon & Ormed, India India N S Remedies India USA Advanced Micronic Devices, India Thermometer Division Unilever, India Eurocor GMBH, Germany CSI, USA

17 Consolidated Financial Summary Year-ended USD Mn. USD Mn. March 31st Sales EBITDA PAT EBITDA/Sales(%) 30% 33% PAT/Sales(%) 23% 24% EPS (Rs.) Dividend (%) As on March 31st Net Block Net Worth Capital Employed % 100% 80% 60% 40% 20% 0% Segment Mix (% to Sales) Medical Equipment Others 2% 3% 25% 23% 73% 74% Interventional Devices FY11 Geographic Mix (% to Sales) Note: FY2011 and FY2010 Profit & Loss and Balance Sheet figures are not comparable as the performance of the three acquisitions that were made in FY2011 has been consolidated with that year s figures % 9.31% % 61.30% 52% 40% 8% US Europe Asia ROW Medical Equipment Europe Latin America ROW Interventional Devices 16

18 Promoters and Shareholding Chairman & Managing Director Vinod Ramnani Executive Director Usha Ramnani Promoter Directors Jayesh Patel 32% 40% 28% Thomas Dietiker Promoters Institutions Others As on June 30,

19 # 83, Electronics City, Bengaluru , Karnataka, India Phone : / 41/ 42 Fax : ir@optoindia.com Web: